Key facts
- This page summarizes Brad D. Smith's Form 4 filing for HUMANA INC (HUM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 19 Sep 2022, 11:15.
Brad D. Smith - 15 Sep 2022 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Director
- Issuer ticker
- HUM
- Reported as of
- 15 Sep 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Sep 2022, 11:15:52 UTC
- Prior SEC filing
- 06 Sep 2022
- Next SEC filing
- 04 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- Brad D. Smith
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brad D. Smith filed Form 4 for HUMANA INC (HUM) on 19 Sep 2022.
Change
- Previous filing in this sequence was filed on 06 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 15 Sep 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +386
- Change %
- Price
- $0.000000
- Shares after
- 386
- Date
- 15 Sep 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 386
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F2
Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 9/15/2023 and forfeited in its entirety if service is less than one year.